McKesson Hit With FCA Suit Alleging Misbranded Drugs
A medical company is accusing pharmaceutical distribution company McKesson Corp. of opening deliberately overfilled sterile vials of drugs, skimming the excess medicine and then transferring the drugs into single-dose pre-filled syringes in a...To view the full article, register now.
Already a subscriber? Click here to view full article